{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004994.3:c.4316G>A",
          "cDNA Change": {
            "transcript": "NM_004994.3",
            "ref": "G",
            "alt": "A",
            "position": "4316"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "G",
            "position": "1441"
          },
          "Description in input context": "R1441G"
        },
        {
          "HGVS": "NM_004994.3:c.5096C>T",
          "cDNA Change": {
            "transcript": "NM_004994.3",
            "ref": "C",
            "alt": "T",
            "position": "5096"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_004994.3:c.6056G>T",
          "cDNA Change": {
            "transcript": "NM_004994.3",
            "ref": "G",
            "alt": "T",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "V",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005128"
  },
  "Experiment Method": [
    {
      "Assay Method": "Affinity purification and mass spectrometry",
      "Material used": {
        "Material Source": "Mouse brain tissue",
        "Material Name": "LRRK2 protein",
        "Description": "LRRK2 protein was purified using affinity tags and analyzed by mass spectrometry to identify phosphorylation sites."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004994.3:c.4316G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired 14-3-3 binding",
          "Result Description": "Phosphorylation levels at S935 were reduced in R1441G variants."
        },
        {
          "Variant": "NM_004994.3:c.5096C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired 14-3-3 binding",
          "Result Description": "Phosphorylation at S935 was disrupted in Y1699C variants."
        },
        {
          "Variant": "NM_004994.3:c.6056G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired 14-3-3 binding",
          "Result Description": "Phosphorylation at S935 was significantly reduced in G2019S variants."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple biological replicates were used to validate phosphorylation site identification."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Mass spectrometry data was averaged across technical replicates."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein was used as a positive control for phosphorylation assays."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Unphosphorylated LRRK2 protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey test for phosphorylation level comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels ≥ 80% of wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels < 50% of wild-type controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro kinase assay",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "LRRK2-expressing cells",
        "Description": "LRRK2 phosphorylation was tested using recombinant kinase assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004994.3:c.4316G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "R1441G variants showed 40% reduced kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_004994.3:c.5096C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "Y1699C variants exhibited 60% reduced kinase activity."
        },
        {
          "Variant": "NM_004994.3:c.6056G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "G2019S variants showed 70% reduced kinase activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent cell lines were tested for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each kinase assay was repeated three times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "LRRK2 without kinase domain was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "T-test for kinase activity comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity ≥ 80% of wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity < 50% of wild-type controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}